TMWMX Fees and Costs — Washington Mutual Investors Fund, Class 529-T
Data updated: 2026-09-28
The net expense ratio is 0.61%: a 0.22% management fee, a 0.25% 12b-1 fee plus 0.14% other expenses. This share class carries a maximum front-end sales load of 2.50%. In fiscal 2026 the fund paid $19.4M in broker commissions, 0.0095% of average net assets, and portfolio turnover was 32%.
TMWMX Fees and Expenses
Annual operating expenses and sales charges of TMWMX. Prospectus, as of June 30, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.22% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.14% |
| Gross expense ratio | 0.61% |
| Fee waiver | — |
| Net expense ratio | 0.61% |
| Sales charges | |
|---|---|
| Max front load | 2.50% |
| Max deferred load | 0.00% |
| Redemption fee | 0.00% |
| 30-day yield | 1.52% |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
TMWMX Costs Over Time
On $10,000 invested in TMWMX, assuming 5% a year before costs, total costs come to $700 over 5 years, cutting the return by 1.18% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $250 | $250 | $250 |
| Fund expenses (net expense ratio 0.61%) | $62 | $196 | $341 |
| Trading costs (broker commissions) | $1 | $3 | $5 |
| Lost growth on money paid in costs | $13 | $49 | $104 |
| Total costs | $326 | $498 | $700 |
| Value after costs | $10,174 | $11,078 | $12,063 |
| Impact on return, per year | 3.26% | 1.53% | 1.18% |
TMWMX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending April 30, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0095%
- Total broker commissions: $19.4M
- Bought from dealers (principal trades, not a cost): $1.0B
- Portfolio turnover (prospectus): 32%
- Securities on loan, average value: $313.4M
- Net income from securities lending: $2.5M (0.001% of average net assets)
TMWMX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley & Co. LLC | $3.1M | 22.24% |
| Goldman Sachs & Co. LLC | $2.1M | 15.31% |
| Bank of America, N.A. | $1.6M | 11.61% |
| J.P. Morgan Securities LLC | $1.4M | 10.34% |
| Citigroup Global Markets Inc. | $1.2M | 8.57% |
| Barclays Bank PLC | $1.1M | 7.61% |
| Jefferies & Company Inc. | $1.0M | 7.50% |
| RBC Capital Markets LLC | $815K | 5.90% |
| UBS AG | $769K | 5.57% |
| TD Securities (USA) | $737K | 5.34% |
TMWMX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Bank of America, N.A. | $642.7M | 62.42% |
| J.P. Morgan Securities LLC | $280.0M | 27.19% |
| Citigroup Global Markets Inc. | $107.0M | 10.39% |
Washington Mutual Investors Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| FWMIX | Class F-3 | 0.26% | none |
| RWMGX | Class R-6 | 0.26% | none |
| FWWMX | Class 529-F-3 | 0.31% | none |
| RWMFX | Class R-5 | 0.31% | none |
| FWMMX | Class 529-F-2 | 0.35% | none |
| WMFFX | Class F-2 | 0.37% | none |
| RWMHX | Class R-5E | 0.41% | none |
| AWSHX | Class A | 0.55% | 5.75% |
| TWMMX | Class T | 0.56% | 2.50% |
| CWMAX | Class 529-A | 0.58% | 3.50% |
| RWMEX | Class R-4 | 0.61% | none |
| TMWMX | Class 529-T | 0.61% | 2.50% |
| WSHFX | Class F-1 | 0.62% | none |
| CWMFX | Class 529-F-1 | 0.68% | none |
| CWMEX | Class 529-E | 0.84% | none |
| RWMCX | Class R-3 | 0.91% | none |
| RWEBX | Class R-2E | 1.06% | none |
| WSHCX | Class C | 1.31% | none |
| RWMAX | Class R-1 | 1.35% | none |
| RWMBX | Class R-2 | 1.35% | none |
| CWMCX | Class 529-C | 1.36% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.